Sign inJoin waitlistJoin the waitlist

Lewis Hsu

Interim Chief, Section of Hematology-Oncology · UIC Department of Pediatrics

Credentials: · · · · · ·

History

Section of Hematology-Oncology · UIC Department of Pediatrics
Present
UIC
2011–Present

Pediatric Hematology/Oncology
University of Illinois College of Medicine at Chicago
1994–1997
Yale-New Haven Hospital
1991–1994
Pediatrics
Children's Hospital of Philadelphia
1988–1991
University of Rochester School of Medicine and Dentistry
1984–1988
Pediatric Hematology/Oncology Fellow
University of Illinois College of Medicine at Chicago

Research

Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography
New England Journal of Medicine · 1998 · 1,411 citations
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease
New England Journal of Medicine · 2018 · 451 citations
Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease
Blood · 2000 · 273 citations

Victor Gordeuk
24 papers
Jane Hankins
12 papers
JK
Julie Kanter
11 papers
Mark Gladwin
11 papers
CD
Carlton Dampier
10 papers
Allison King
9 papers · 1 as a resident
Jeffrey Glassberg
8 papers
LK
Lakshmanan Krishnamurti
8 papers
Santosh Saraf
8 papers
Winfred Wang
8 papers
Claudia Morris
7 papers · 4 as a resident
Kim Smith-Whitley
7 papers

Grants

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
National Heart, Lung, and Blood Institute · R01
PI · $7.6M · University of Alabama at Birmingham
2022–2027
Improving Sickle Cell Care in Adolescents & Adults in Chicago (ISAAC)
National Heart, Lung, and Blood Institute · U01
PI · $5.1M · University of Illinois at Chicago
2016–2023
Marian Anderson Sickle Cell Center-Sickle Cell Disease Clinical Research Network
National Heart, Lung, and Blood Institute · U10
Contact PI · $155.4K · Drexel University
2006–2011
Transgenic Model for Sickle Acute Chest Syndrome
National Heart, Lung, and Blood Institute · K08
Contact PI · $459.7K · Emory University
1998–2002

Clinical trials

Risk Clinical Stratification of Sickle Cell Disease in Nigeria, Assessment of Efficacy/Safety of Hydroxyurea Treatment
Principal investigator · Completed · Phase 4
Loyola University
2014–2022
Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence
Study chair · Completed
University of Texas Southwestern Medical Center
2005–2008